Prognostic significance of Ki-67 expression in transitional cell bladder carcinoma after radical cystectomy

Pathology Research and Practice

Volumn 193, Issue 8, 1997, Pages 551-556

  Suwa, Yutaka ^a   Takano, Yasuo ^b   Iki, Masayuki ^c   Asakura, Tomoyuki ^a   Noguchi, Sumio ^a   Masuda, Mitsunobu ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF FUKUI   (Japan)

Author keywords

Bladder neoplasms; Cystectomy; Ki 67 antibody

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER SURVIVAL; CORRELATION FUNCTION; CYSTECTOMY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; TRANSITIONAL CELL CARCINOMA;

EID: 0030659774     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(97)80013-1     Document Type: Article

References (23)

1. Brendler CB, Steinberg GD, Marchall FF, Mostwin JL, Walsh PC (1990) Local recurrence and survival following nerve-sparing radical cystoprostatectomy. J Urol 144: 1137-1141
2. Bush C, Price P, Norton J, Parkins CS, Bailey MJ, Boyd J, Jones CR, A'Hern RO, Horwich A (1991) Proliferation in human bladder carcinomas measured by Ki-67 antibody labelling: its potential clinical importance. BR J Cancer 64: 357-360
3. Fontana D, Bellina M, Gubetta L, Fasolis G, Rolle L, Scoffone C, Porpiglia F, Colombo M, Tarabuzzi R, Leonardo E (1992) Monoclonal antibody Ki-67 in the study of the proliferative activity of bladder carcinoma. J Urol 148: 1149-1151
4. Gerdes J, Scwab U, Lemke H, Stein H (1993) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31: 13-20
5. Gratzner HG (1982) Monoclonal antibody to 5-bromoand 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science 218: 474-475
6. Hermaneck P, Sobin L (1992) TNM classification of malignant tumours: urinary bladder, 4th ed, pp 154-156. Springer-Verlag, New York
7. Jewett H, King LR, Shelley WM (1964) A study of 365 cases of infiltrating bladder cancer: relation of certain pathological characteristics to prognosis after extirpation. J Urol 92: 668-678
8. Kubota Y, Petras BE, Easley KA, Bauer TWB, Tubbs RR, Fazio VW (1992) Ki-67-determined growth fraction versus standard staging and grading parameters in colorectal carcinoma. A multivariate analysis. Cancer 70: 2602-2609
9. Malmsrtrom PU, Rintala E, Wahlqvist R, Hellstrom P, Hellsten S, Hannisdal E, members of the Nordic cooperative bladder cancer group (1996) Five-year follow-up of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic cystectomy trial I. J Urol 755: 1903-1906
10. Marshall VF (1952) The relation of the preoperative estimate to the pathologic demonstration of the extent of vesical neoplasms. J Urol 68: 714-723
11. Masuda M, Iki M, Takano Y, Asakura T, Noguchi S, Ikeda I, Kubota Y, Hosaka M (1996) Prognostic significance of Ki-67 labeling index in urothelial tumors of the renal pelvis and ureter. J Urol 155: 1877-1881
12. Mazerolles C, Rishmann P, Chopin D, Popov Z, Malavaud B, Selves J, Neulat-Duga I, Bellot J, Delsol G (1994) Usefulness of MIB1 monoclonal antibody in assessing the proliferative index in human bladder carcinoma: comparison with Ki-67 antibody. Histopathology 25: 563-568
13. Mulder AH, Hootegem JCSPV, Sylvester R, Kate FJWT, Kurth KH, Oooms ECM, Kwast HVD (1992) Prognostic factors in bladder carcinomas: histologic parameters and expression of a cell cycle-related nuclear antigen (Ki-67). J Pathol 166: 37-43
14. Okamura K, Miyake K, Koshikawa T, Asai J (1990) Growth fractions of transitional cell carcinomas of the bladder defined by the monoclonal antibody KI-67. J Urol 144: 875-878
15. Pagano F, Bassi P, Galetti TP, Meneghini A, Milani C, Artibani W, Garbeglio A (1991) Results of contemporary radical cystectcomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 145: 45-50
16. Skinner DG, Daniels JR, Russell CA, Lieskovsky G, Boyd SD, Nichols P, Kern W, Sakamoto J, Krailo M, Groshen S (1991) The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol 145: 459-467
17. Stavropoulos NE, Ioackim-Velogianni E, Hastazeris K, Kitsiou E, Stefanaki S, Agnantis N (1993) Growth fractions in bladder cancer defined by KI67: association with cancer grade, category and recurrence rate of superficial lesions. Br J Urol 72: 736-739
18. Stockle M, Meyenburg W, Wellek S, Voges GE, Rossmann M, Gertenbach U, Thuroff JW, Huber C, Hohenfellner R (1995) Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience. J Urol 153: 47-52
19. Tachibana M, Deguchi N, Jitsukawa S, Baba S, Hata M, Tazaki H (1991) Quantification of cell kinetic characteristics using flow cytometric measurements of deoxyrubionucleic acid and bromodeoxyuridine for bladder cancer. J Urol 145: 963-867
20. Thrasher JB, Crawford ED (1993) Current management of invasive and metastatic transitional cell carcinoma of the bladder. J Urol 149: 957-972
21. Tsujihashi H, Nakanishi A, Matsuda H, Uejima S, Kurita T (1991) Cell proliferation of human bladder tumors determined by BRDURD and KI-67 immunostaining. J Urol 145: 846-849
22. Vielh P, Chevillard S, Mosseri V, Donatini B, Magdelenat H (1990) Ki-67 index and s-phase fraction with prognostic factors. Am J Clin Pathol 94: 681-686
23. Yonemura Y, Ooyama S, Sugiyama K, Ninomiya I, Kamala T, Yamaguchi A, Matsumoto H, Miyazaki I (1990) Growth fractions in gastric carcinomas determined with monoclonal antibody KI-67. Cancer 65: 1130-1134